Nivolumab immunotherapy safe and feasible during chemo-radiotherapy for advanced head and neck cancer

Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered safely in conjunction with radiotherapy and chemotherapy for patients with newly diagnosed local-regionally advanced head and neck cancers.
PR Newswire

Leave a Reply

  • (will not be published)

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>